Hiroyuki Kobayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroyuki Kobayashi has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Atsuyuki Yamataka
20 shared publicationsGeoffrey J. Lane
18 shared publicationsTakeshi Miyano
Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan
16 shared publicationsHiroyuki Koga
Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan
5 shared publicationsTsuyoshi Tamura
5 shared publicationsJunichi Kusafuka
3 shared publications
Latest Publications
- 31 December 2007
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 42 (12) , 2062-2066
The mechanism of intestinal motility in homozygous mutant Ncx/Hox11L.1-deficient mice—a model for intestinal neuronal dysplasia
- 31 December 2007
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 42 (12) , 2062-2066
The mechanism of intestinal motility in homozygous mutant Ncx/Hox11L.1-deficient mice—a model for intestinal neuronal dysplasia
- 7 August 2007
- Published by Springer Nature in Pediatric Surgery International
- Vol. 23 (10) , 931-934
Magnetic resonance angiography versus endoscopy for the assessment of gastroesophageal varices in biliary atresia
This study was undertaken to compare magnetic resonance angiography (MRA) and gastrointestinal tract endoscopy (ENDO) for detecting varices in postoperative biliary atresia (BA) patients. Thirty-four BA patients were divided into groups according to age and liver function; group 1: 1–4 years old; group 2: 5–9 years old; group 3: over 10 years old; group A: normal liver function; and group B: moderate liver dysfunction. All subjects had MRA and ENDO. ENDO showed esophageal or gastric varices in 16 of 34 subjects. MRA depicted gastroesophageal vessels in 12 of 16 cases with varices on ENDO (sensitivity: 75%). Two subjects appeared to have varices on MRA that could not be confirmed on ENDO. Sixteen subjects had no varices on ENDO and normal MRA (specificity: 88.9%). Sensitivities and specificities of MRA for detecting varices were 20 (1/5) and 100% (6/6) in group 1 (n = 11), 100 (6/6) and 66.7% (4/6) in group 2 (n = 12), 100 (5/5) and 100% (6/6) in group 3 (n = 11), 100 (8/8) and 100% (9/9) in group A (n = 17), 50 (4/8) and 77.8% (7/9) in group B (n = 17), respectively. From these findings, MRA was not accurate in BA patients less than 10 years old or with moderate liver dysfunction. Therefore, periodic endoscopic examination is recommended for the accurate assessment and follow-up of varices in postoperative BA patients.
- 7 August 2007
- Published by Springer Nature in Pediatric Surgery International
- Vol. 23 (10) , 931-934
Magnetic resonance angiography versus endoscopy for the assessment of gastroesophageal varices in biliary atresia
This study was undertaken to compare magnetic resonance angiography (MRA) and gastrointestinal tract endoscopy (ENDO) for detecting varices in postoperative biliary atresia (BA) patients. Thirty-four BA patients were divided into groups according to age and liver function; group 1: 1–4 years old; group 2: 5–9 years old; group 3: over 10 years old; group A: normal liver function; and group B: moderate liver dysfunction. All subjects had MRA and ENDO. ENDO showed esophageal or gastric varices in 16 of 34 subjects. MRA depicted gastroesophageal vessels in 12 of 16 cases with varices on ENDO (sensitivity: 75%). Two subjects appeared to have varices on MRA that could not be confirmed on ENDO. Sixteen subjects had no varices on ENDO and normal MRA (specificity: 88.9%). Sensitivities and specificities of MRA for detecting varices were 20 (1/5) and 100% (6/6) in group 1 (n = 11), 100 (6/6) and 66.7% (4/6) in group 2 (n = 12), 100 (5/5) and 100% (6/6) in group 3 (n = 11), 100 (8/8) and 100% (9/9) in group A (n = 17), 50 (4/8) and 77.8% (7/9) in group B (n = 17), respectively. From these findings, MRA was not accurate in BA patients less than 10 years old or with moderate liver dysfunction. Therefore, periodic endoscopic examination is recommended for the accurate assessment and follow-up of varices in postoperative BA patients.
- 1 June 2007
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 42 (6) , 987-991
Maternal microchimerism in biliary atresia
- 1 June 2007
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 42 (6) , 987-991
Maternal microchimerism in biliary atresia
- 8 February 2007
- Published by Springer Nature in Pediatric Surgery International
- Vol. 23 (4) , 343-347
Inchin-ko-to prevents medium-term liver fibrosis in postoperative biliary atresia patients
The oriental herbal formulation inchin-ko-to (ICKT) inhibits liver cell apoptosis induced by transforming growth factor-beta 1 (TGF-β1). This study evaluated the effect of ICKT on serum markers of liver function and liver fibrosis in postoperative biliary atresia (BA) patients. Twenty-one postoperative BA patients with elevated GOT, GPT and γ-GTP, but normal serum total bilirubin levels, were divided into two groups arbitrarily; an ICKT group (n = 12), and a no-ICKT group (n = 9). Serum markers of liver function [GOT, GPT, γ-GTP, total bile acids (TBA)], and serum markers of liver fibrosis [hyaluronic acid (HA), type IV collagen (C-IV)], were measured in both groups at the beginning of the study, and at 1, and 3 years after the beginning of the study and the results compared statistically. All patients tolerated ICKT well, and there were no side effects. In the ICKT group, mean serum HA levels were significantly decreased at 1 year (P < 0.012), and at 3 years, both mean serum HA and C-IV were significantly decreased (P < 0.001 and P < 0.003, respectively). However, mean serum levels of GOT, GPT, γ-GTP, and TBA did not change significantly following ICKT use for any length of time (all P > 0.05). Administration of ICKT in postoperative BA patients appears to lower the serum levels of markers of fibrosis in the medium-term. Whether this in fact correlates with prevention cannot be determined from this paper, but ICKT would appear to protect against liver fibrosis. Long-term studies are required to determine the exact role ICKT plays in prognosis of BA patients.
- 8 February 2007
- Published by Springer Nature in Pediatric Surgery International
- Vol. 23 (4) , 343-347
Inchin-ko-to prevents medium-term liver fibrosis in postoperative biliary atresia patients
The oriental herbal formulation inchin-ko-to (ICKT) inhibits liver cell apoptosis induced by transforming growth factor-beta 1 (TGF-β1). This study evaluated the effect of ICKT on serum markers of liver function and liver fibrosis in postoperative biliary atresia (BA) patients. Twenty-one postoperative BA patients with elevated GOT, GPT and γ-GTP, but normal serum total bilirubin levels, were divided into two groups arbitrarily; an ICKT group (n = 12), and a no-ICKT group (n = 9). Serum markers of liver function [GOT, GPT, γ-GTP, total bile acids (TBA)], and serum markers of liver fibrosis [hyaluronic acid (HA), type IV collagen (C-IV)], were measured in both groups at the beginning of the study, and at 1, and 3 years after the beginning of the study and the results compared statistically. All patients tolerated ICKT well, and there were no side effects. In the ICKT group, mean serum HA levels were significantly decreased at 1 year (P < 0.012), and at 3 years, both mean serum HA and C-IV were significantly decreased (P < 0.001 and P < 0.003, respectively). However, mean serum levels of GOT, GPT, γ-GTP, and TBA did not change significantly following ICKT use for any length of time (all P > 0.05). Administration of ICKT in postoperative BA patients appears to lower the serum levels of markers of fibrosis in the medium-term. Whether this in fact correlates with prevention cannot be determined from this paper, but ICKT would appear to protect against liver fibrosis. Long-term studies are required to determine the exact role ICKT plays in prognosis of BA patients.
- 6 January 2007
- Published by Springer Nature in Pediatric Surgery International
- Vol. 23 (5) , 487-491
Serum monocyte chemotactic protein-1 levels in congenital diaphragmatic hernia
To measure serum monocyte chemotactic protein-1 (MCP-1) in patients with congenital diaphragmatic hernia (CDH) and investigate its relationship to the development of persistent pulmonary hypertension (PPH). Serum MCP-1 was measured in 13 neonates with high risk for CDH at the time of diagnosis and postoperatively, and in five age-matched controls using an ELISA system. The 13 CDH subjects were divided into four groups according to the presence of PPH and outcome. Group I (severe-pre group): subjects with severe PPH who died prior to surgery (n = 5); Group II (mild-pre group): subjects with mild PPH controlled by medications (n = 8); Group IIa (severe-post group): subjects who subsequently developed severe PPH postoperatively and died (n = 3); and Group IIb (mild-post group): subjects who continued to have mild PPH controlled by medications. We also examined nitrofen-induced hypoplastic lungs from five rat fetuses with CDH and five control lung specimens for MCP-1 using immunohistochemistry. Mean serum MCP-1 in Group I was (1038.0 ± 95.8 pg/ml), which was significantly higher than Group II (444.9 ± 39.7 pg/ml) (P < 0.0001) and controls (147.3 ± 11.3 pg/ml) (P < 0.0001). Postoperatively, Group IIa was significantly higher than Group IIb from 24 to 120 h postoperatively (P < 0.001). In Group IIb serum MCP-1 did not rise at all between 24 and 120 h postoperatively. Hypoplastic fetal rat CDH lungs had strong expression of MCP-1 compared with control lungs. Up-regulated expression and high circulating levels of MCP-1 in CDH patients with PPH suggest that MCP-1 may play a role in the development of PPH in CDH.
- 6 January 2007
- Published by Springer Nature in Pediatric Surgery International
- Vol. 23 (5) , 487-491
Serum monocyte chemotactic protein-1 levels in congenital diaphragmatic hernia
To measure serum monocyte chemotactic protein-1 (MCP-1) in patients with congenital diaphragmatic hernia (CDH) and investigate its relationship to the development of persistent pulmonary hypertension (PPH). Serum MCP-1 was measured in 13 neonates with high risk for CDH at the time of diagnosis and postoperatively, and in five age-matched controls using an ELISA system. The 13 CDH subjects were divided into four groups according to the presence of PPH and outcome. Group I (severe-pre group): subjects with severe PPH who died prior to surgery (n = 5); Group II (mild-pre group): subjects with mild PPH controlled by medications (n = 8); Group IIa (severe-post group): subjects who subsequently developed severe PPH postoperatively and died (n = 3); and Group IIb (mild-post group): subjects who continued to have mild PPH controlled by medications. We also examined nitrofen-induced hypoplastic lungs from five rat fetuses with CDH and five control lung specimens for MCP-1 using immunohistochemistry. Mean serum MCP-1 in Group I was (1038.0 ± 95.8 pg/ml), which was significantly higher than Group II (444.9 ± 39.7 pg/ml) (P < 0.0001) and controls (147.3 ± 11.3 pg/ml) (P < 0.0001). Postoperatively, Group IIa was significantly higher than Group IIb from 24 to 120 h postoperatively (P < 0.001). In Group IIb serum MCP-1 did not rise at all between 24 and 120 h postoperatively. Hypoplastic fetal rat CDH lungs had strong expression of MCP-1 compared with control lungs. Up-regulated expression and high circulating levels of MCP-1 in CDH patients with PPH suggest that MCP-1 may play a role in the development of PPH in CDH.
- 1 December 2006
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 41 (12) , 1967-1972
The role of monocyte chemoattractant protein-1 in biliary atresia
- 1 December 2006
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 41 (12) , 1967-1972
The role of monocyte chemoattractant protein-1 in biliary atresia
- 1 May 2006
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 41 (5) , e19-e22
Innovative modification of the hepatic portoenterostomy. Our experience of treating biliary atresia
- 1 May 2006
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 41 (5) , e19-e22
Innovative modification of the hepatic portoenterostomy. Our experience of treating biliary atresia
- 28 September 2005
- Published by Springer Nature in Pediatric Surgery International
- Vol. 21 (11) , 889-898
Complete innervation profile of whole bowel resected at pull-through for Hirschsprung’s disease. Unexpected findings
- 28 September 2005
- Published by Springer Nature in Pediatric Surgery International
- Vol. 21 (11) , 889-898
Complete innervation profile of whole bowel resected at pull-through for Hirschsprung’s disease. Unexpected findings
- 31 August 2005
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 40 (8) , 1366-1367
Are serum prolyl 4-hydroxylase useful as noninvasive markers of liver fibrosis in patients with biliary atresia?
- 31 August 2005
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 40 (8) , 1366-1367
Are serum prolyl 4-hydroxylase useful as noninvasive markers of liver fibrosis in patients with biliary atresia?
- 25 August 2005
- Published by Springer Nature in Pediatric Surgery International
- Vol. 21 (11) , 883-888
Disseminated mixed intestinal dysmotility(DMID): a new intestinal ganglion cell disorder?
- 25 August 2005
- Published by Springer Nature in Pediatric Surgery International
- Vol. 21 (11) , 883-888
Disseminated mixed intestinal dysmotility(DMID): a new intestinal ganglion cell disorder?